Kastritis, E., Kyrtsonis, M.-C., Morel, P., Gavriatopoulou, M., Hatjiharissi, E., Symeonidis, A. S., Vassou, A., Repousis, P., Delimpasi, S., Sioni, A., Michalis, E., Michael, M., Vervessou, E., Voulgarelis, M., Tsatalas, C., Terpos, E. and Dimopoulos, M. A. (2015) “Competing risk survival analysis in patients with symptomatic Waldenström macroglobulinemia: the impact of disease unrelated mortality and of rituximab-based primary therapy”, Haematologica. Pavia, Italy, 100(11), pp. e446-e449. doi: 10.3324/haematol.2015.124149.